SCHEMBL2461280

SCHEMBL2461280

BrC[C@@H]1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL78600 1.00
SCHEMBL4180170 1.00
Ammonia Solution, Strong SCHEMBL10573407 0.96
Trimethylammonium SCHEMBL456269 0.87
Dimethylamine SCHEMBL21632308 0.87
Bicarbonate SCHEMBL10628071 0.85
SCHEMBL9584467 0.85 ALDH1A1 (0.72)
SCHEMBL455128 0.83 ALDH1A1 (0.36)
Diethylamine SCHEMBL21632306 0.81 TP53 (0.40)
Ether SCHEMBL5400744 0.81 SMN1; SMN2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111056942-B Preparation method of 3-hydroxy-6-oxohexanoate 新发药业有限公司 2021-08-17 CN claimed
CN-111056942-A Preparation method of 3-hydroxy-6-oxohexanoate 新发药业有限公司 2020-04-24 CN claimed
US-12454529-B2 Piperazine cyclic ureas Sironax Ltd. (KY) 2025-10-28 US disclosed
CN-115697991-B Piperazine cyclic ureas 维泰瑞隆有限公司 2024-11-22 CN disclosed
US-20230203019-A1 Piperazine Cyclic Ureas SIRONAX (BEIJING) CO., LTD. (CN) 2023-06-29 US disclosed
US-20230203019-A1 Piperazine Cyclic Ureas SIRONAX (BEIJING) CO., LTD. (CN) 2023-06-29 US disclosed
CN-115697991-A Piperazine cyclic ureas 维泰瑞隆有限公司 2023-02-03 CN disclosed
CN-111056942-B Preparation method of 3-hydroxy-6-oxohexanoate 新发药业有限公司 2021-08-17 CN disclosed
CN-111056942-A Preparation method of 3-hydroxy-6-oxohexanoate 新发药业有限公司 2020-04-24 CN disclosed
EP-2890672-B1 PROCESSES FOR PREPARING INTERMEDIATES FOR THE MANUFACTURE OF NEP INHIBITORS NOVARTIS AG (CH) 2018-05-30 EP disclosed
US-9624163-B2 Process for preparing intermediates useful in the manufacture of NEP inhibitors NOVARTIS AG (CH) 2017-04-18 US disclosed
EP-1292602-A1 NEW CHIRAL SALEN CATALYST AND METHODS FOR THE PREPARATION OF CHIRAL COMPOUNDS FROM RACEMIC EPOXIDES BY USING NEW CATALYST RS Tech Corp. (KR) 2003-03-19 EP disclosed
US-20030032821-A1 Novel chiral salen catalysts, and a process for preparing chiral compounds from racemic epoxides for using them RSTECH CO., LTD. (KR) 2003-02-13 US disclosed
WO-2003002582-A1 NEW CHIRAL SALEN CATALYST AND METHODS FOR THE PREPARATION OF CHIRAL COMPOUNDS FROM RACEMIC EPOXIDES BY USING NEW CATALYST RS TECH CORP. (KR) 2003-01-09 WO disclosed
US-5602108-A Semisynthetic diastereomerically pure N-glycidylanthracyclines, a process for the stereoselective preparation thereof as the use thereof as cytostatics BEHRINGWERKE AKTIENGESELLSCHAFT (DE) 1997-02-11 US disclosed
US-5250715-A Optically active 2-methylenepentane derivative and process for preparing same DAISO CO., LTD. (JP) 1993-10-05 US disclosed
US-5216187-A Optically active 2-methylenepentane derivative and process for preparing same DAISO CO., LTD. (JP) 1993-06-01 US disclosed
US-5200538-A Optically active 2-methylenecyclopentanone derivative and process for preparing same DAISO CO., LTD. (JP) 1993-04-06 US disclosed
US-5180844-A Optically active 2-methylenecyclopentanone derivative and process for preparing same DAISO CO., LTD. (JP) 1993-01-19 US disclosed
US-5136066-A Process for preparing optically active cyclopentenone derivative DAISO CO., LTD. (JP) 1992-08-04 US disclosed